z-logo
Premium
Efficacy of noninvasive multisource radiofrequency treatment on periorbital rhytids using an imaging device
Author(s) -
AlMuriesh Maher,
Zhang Xingping,
Wang Qing,
Huang Changzheng,
An Xiangjie
Publication year - 2019
Publication title -
lasers in surgery and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.888
H-Index - 112
eISSN - 1096-9101
pISSN - 0196-8092
DOI - 10.1002/lsm.23038
Subject(s) - medicine , patient satisfaction , guideline , prospective cohort study , treatment protocol , surgery , clinical efficacy , dermatology , pathology
Objective To evaluate the efficacy of the multisource radiofrequency in periorbital wrinkles treatment using a VISIA imager. Methods This is a prospective cohort study involving 30 sites in 15 patients. Inclusion criteria: healthy subjects with periorbital wrinkles. Patients underwent five treatment sessions for each site using multisource radiofrequency. VISIA imager was used before and after each treatment, and in 12‐week follow‐up. The wrinkle scores were calculated and compared between baseline and 12‐week follow‐up. Changing in periorbital wrinkles were evaluated by blinded dermatologist using a scale of 0–3. After the study, patients rated their satisfaction using a scale of 0–3. The study protocol was approved by our institutional human research review committee, according to the ethics guideline of Helsinki (1975). Results The effect of treatment on subjects on follow‐up compared to baseline showed a highly significant difference with P ‐values <0.05. Only two patients had no improvement according to blind dermatologist assessment of photographs. Thirteen patients reported satisfaction scale between 1 and 3. Conclusions The multisource radiofrequency is safe and effective in reducing periorbital rhytids, and with the help of VISIA imager we can get more objective data to evaluate the efficacy of radiofrequency treatment on the periorbital areas. Lasers Surg. Med. 51:251–255, 2019. © 2018 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here